{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:06:16Z","timestamp":1765422376827,"version":"3.38.0"},"reference-count":48,"publisher":"Medical Association of Nippon Medical School","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2025,2,25]]},"DOI":"10.1272\/jnms.jnms.2025_92-116","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:13:33Z","timestamp":1741299213000},"page":"14-21","source":"Crossref","is-referenced-by-count":2,"title":["Perioperative Anesthesia Management: The Role of MicroRNAs"],"prefix":"10.1272","volume":"92","author":[{"given":"Masashi","family":"Ishikawa","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Alkire BC, Raykar NP, Shrime MG, et al. Global access to surgical care: a modelling study. Lancet Glob Health. 2015;3 (6):e316-23. doi: 10.1016\/S2214-109X(15)70115-4","DOI":"10.1016\/S2214-109X(15)70115-4"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Nepogodiev D, Martin J, Biccard B, Makupe A, Bhangu A; National Institute for Health Research Global Health Research Unit on Global Surgery. Global burden of postoperative death. Lancet. 2019;393 (10170):401. doi: 10.1016\/S0140-6736(18)33139-8","DOI":"10.1016\/S0140-6736(18)33139-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75 (5):843-54. doi: 10.1016\/0092-8674(93)90529-y","DOI":"10.1016\/0092-8674(93)90529-Y"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Chen X, Zhou JY, Zhou JY. MicroRNA-34a: role in cancer and cardiovascular disease. Curr Drug Targets. 2014;15 (4):361-73. doi: 10.2174\/1389450115666140120102935","DOI":"10.2174\/1389450115666140120102935"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Wu Y, Crawford M, Mao Y, et al. Therapeutic delivery of microRNA-29b by cationic lipoplexes for lung cancer. Mol Ther Nucleic Acids. 2013;2 (4):e84. doi: 10.1038\/mtna.2013.14","DOI":"10.1038\/mtna.2013.14"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Moro M, Di Paolo D, Milione M, et al. Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models. J Control Release. 2019;308:44-56. doi: 10.1016\/j.jconrel.2019.07.006","DOI":"10.1016\/j.jconrel.2019.07.006"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ishikawa M, Tanaka S, Arai M, Genda Y, Sakamoto A. Differences in microRNA changes of healthy rat liver between sevoflurane and propofol anesthesia. Anesthesiology. 2012;117 (6):1245-52. doi: 10.1097\/ALN.0b013e3182746676","DOI":"10.1097\/ALN.0b013e3182746676"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GA. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther. 2022;7 (1):121. doi: 10.1038\/s41392-022-00975-3","DOI":"10.1038\/s41392-022-00975-3"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Lam JK, Chow MY, Zhang Y, Leung SW. siRNA versus miRNA as therapeutics for gene silencing. Mol Ther Nucleic Acids. 2015;4 (9):e252. doi: 10.1038\/mtna.2015.23","DOI":"10.1038\/mtna.2015.23"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol. 2005;3 (3):e85. doi: 10.1371\/journal.pbio.0030085","DOI":"10.1371\/journal.pbio.0030085"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37 (5):495-500. doi: 10.1038\/ng1536","DOI":"10.1038\/ng1536"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Karp X, Ambros V. Developmental biology. Encountering microRNAs in cell fate signaling. Science. 2005;310 (5752):1288-9. doi: 10.1126\/science.1121566","DOI":"10.1126\/science.1121566"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303 (5654):83-6. doi: 10.1126\/science.1091903","DOI":"10.1126\/science.1091903"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Stadler BM, Ruohola-Baker H. Small RNAs: keeping stem cells in line. Cell. 2008;132 (4):563-6. doi: 10.1016\/j.cell.2008.02.005","DOI":"10.1016\/j.cell.2008.02.005"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing &apos;stemness&apos;. Nature. 2008;452 (7184):225-9. doi: 10.1038\/nature06642","DOI":"10.1038\/nature06642"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33 (4):1290-7. doi: 10.1093\/nar\/gki200","DOI":"10.1093\/nar\/gki200"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Sakamoto A, Imai J, Nishikawa A, et al. Influence of inhalation anesthesia assessed by comprehensive gene expression profiling. Gene. 2005;356:39-48. doi: 10.1016\/j.gene.2005.03.022","DOI":"10.1016\/j.gene.2005.03.022"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Kobayashi K, Takemori K, Sakamoto A. Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening. Brain Res. 2007;1185:1-7. doi: 10.1016\/j.brainres.2007.09.011","DOI":"10.1016\/j.brainres.2007.09.011"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Nakazato K, Yoshida Y, Takemori K, Kobayashi K, Sakamoto A. Expressions of genes encoding drug-metabolizing enzymes are altered after sevoflurane, isoflurane, propofol or dexmedetomidine anesthesia. Biomed Res. 2009;30 (1):17-24. doi: 10.2220\/biomedres.30.17","DOI":"10.2220\/biomedres.30.17"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Takemori K, Kobayashi K, Sakamoto A. Expression of pulmonary vasoactive factors after sevoflurane anaesthesia in rats: a quantitative real-time polymerase chain reaction study. Br J Anaesth. 2008;100 (2):190-4. doi: 10.1093\/bja\/aem347","DOI":"10.1093\/bja\/aem347"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Tsuboko Y, Sakamoto A. Propofol anaesthesia alters the cerebral proteome differently from sevoflurane anaesthesia. Biomed Res. 2011;32 (1):55-65. doi: 10.2220\/biomedres.32.55","DOI":"10.2220\/biomedres.32.55"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Goto G, Hori Y, Ishikawa M, Tanaka S, Sakamoto A. Changes in the gene expression levels of microRNAs in the rat hippocampus by sevoflurane and propofol anesthesia. Mol Med Rep. 2014;9 (5):1715-22. doi: 10.3892\/mmr.2014.2038","DOI":"10.3892\/mmr.2014.2038"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Tanaka S, Ishikawa M, Arai M, Genda Y, Sakamoto A. Changes in microRNA expression in rat lungs caused by sevoflurane anesthesia: a TaqMan<sup>\u00ae<\/sup> low-density array study. Biomed Res. 2012;33 (5):255-63. doi: 10.2220\/biomedres.33.255","DOI":"10.2220\/biomedres.33.255"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Nazari-Jahantigh M, Wei Y, Noels H, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012;122 (11):4190-202. doi: 10.1172\/JCI61716","DOI":"10.1172\/JCI61716"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M. Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Card Fail. 2010;16 (5):404-10. doi: 10.1016\/j.cardfail.2010.01.002","DOI":"10.1016\/j.cardfail.2010.01.002"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Neudecker V, Brodsky KS, Kreth S, Ginde AA, Eltzschig HK. Emerging roles for microRNAs in perioperative medicine. Anesthesiology. 2016;124 (2):489-506. doi: 10.1097\/ALN.0000000000000969","DOI":"10.1097\/ALN.0000000000000969"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Xiao QX, Cheng CX, Deng R, et al. LncRNA-MYL2-2 and miR-124-3p are associated with perioperative neurocognitive disorders in patients after cardiac surgery. J Invest Surg. 2021;34 (12):1297-303. doi: 10.1080\/08941939.2020.1797949","DOI":"10.1080\/08941939.2020.1797949"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Chang Q, Wu J, An Y, Liu H, Sun Y. Propofol suppresses proliferation, migration, invasion, and tumor growth of liver cancer cells via suppressing cancer susceptibility candidate 9\/phosphatase and tensin homolog\/AKT serine\/threonine kinase\/mechanistic target of rapamycin kinase axis. Hum Exp Toxicol. 2022;41:9603271211065972. doi: 10.1177\/09603271211065972","DOI":"10.1177\/09603271211065972"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Liu L, Dong T, Sheng J. Propofol suppresses gastric cancer progression by regulating circPDSS1\/miR-1324\/SOX4 axis. Cancer Manag Res. 2021;13:6031-43. doi: 10.2147\/CMAR.S312989","DOI":"10.2147\/CMAR.S312989"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Bundscherer AC, Ullrich V, Malsy M, et al. Effects of volatile anesthetics on proliferation and viability of SW480 colon cancer cells in vitro. Anticancer Res. 2019;39 (11):6049-55. doi: 10.21873\/anticanres.13811","DOI":"10.21873\/anticanres.13811"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Iwasaki M, Zhao H, Jaffer T, et al. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget. 2016;7 (18):26042-56. doi: 10.18632\/oncotarget.8304","DOI":"10.18632\/oncotarget.8304"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Yang Y, Hu R, Yan J, et al. Sevoflurane inhibits the malignant potential of head and neck squamous cell carcinoma via activating the hypoxia-inducible factor-1\u03b1 signaling pathway in vitro. Int J Mol Med. 2018;41 (2):995-1002. doi: 10.3892\/ijmm.2017.3306","DOI":"10.3892\/ijmm.2017.3306"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Shen SH, Kwan AL, Chen YY, Wang ZX. Effect of silencing HIF-1\u03b1 on proliferation, invasion and migration of glioblastoma U87 cells. Neurol Sci. 2013;34 (3):365-71. doi: 10.1007\/s10072-012-1010-4","DOI":"10.1007\/s10072-012-1010-4"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Sinha K, Parwez S, Mv S, Yadav A, Siddiqi MI, Banerjee D. Machine learning and biological evaluation-based identification of a potential MMP-9 inhibitor, effective against ovarian cancer cells SKOV3. J Biomol Struct Dyn. 2024;42 (13):6823-41. doi: 10.1080\/07391102.2023.2240416","DOI":"10.1080\/07391102.2023.2240416"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Lin Y, Guo L. GLI1 is involved in HIF-1\u03b1-induced migration, invasion, and epithelial-mesenchymal transition in glioma cells. Folia Histochem Cytobiol. 2022;60 (2):156-66. doi: 10.5603\/FHC.a2022.0014","DOI":"10.5603\/FHC.a2022.0014"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Ishikawa M, Iwasaki M, Zhao H, et al. Inhalational anesthetics inhibit neuroglioma cell proliferation and migration via miR-138, -210 and -335. Int J Mol Sci. 2021;22 (9):4355. doi: 10.3390\/ijms22094355","DOI":"10.3390\/ijms22094355"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ishikawa M, Iwasaki M, Zhao H, et al. Sevoflurane and desflurane exposure enhanced cell proliferation and migration in ovarian cancer cells via miR-210 and miR-138 downregulation. Int J Mol Sci. 2021;22 (4):1826. doi: 10.3390\/ijms22041826","DOI":"10.3390\/ijms22041826"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Buschmann D, Brandes F, Lindemann A, et al. Propofol and Sevoflurane differentially impact microRNAs in circulating extracellular vesicles during colorectal cancer resection: a pilot study. Anesthesiology. 2020;132 (1):107-20. doi: 10.1097\/ALN.0000000000002986","DOI":"10.1097\/ALN.0000000000002986"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Lorenzen JM, Kielstein JT, Hafer C, et al. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2011;6 (7):1540-6. doi: 10.2215\/CJN.00430111","DOI":"10.2215\/CJN.00430111"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene. 2007;26 (19):2799-803. doi: 10.1038\/sj.onc.1210083","DOI":"10.1038\/sj.onc.1210083"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Hong DS, Kang YK, Borad M, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122 (11):1630-7. doi: 10.1038\/s41416-020-0802-1","DOI":"10.1038\/s41416-020-0802-1"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Fan YN, Meley D, Pizer B, See V. Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells. PLoS One. 2014;9 (9):e108514. doi: 10.1371\/journal.pone.0108514","DOI":"10.1371\/journal.pone.0108514"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Wang X, Zhao Y, Lu Q, et al. MiR-34a-5p inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in esophageal squamous cell carcinoma by targeting LEF1 and inactivation of the Hippo-YAP1\/TAZ signaling pathway. J Cancer. 2020;11 (10):3072-81. doi: 10.7150\/jca.39861","DOI":"10.7150\/jca.39861"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Cao W, Fan R, Wang L, et al. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. Tumour Biol. 2013;34 (2):963-71. doi: 10.1007\/s13277-012-0632-8","DOI":"10.1007\/s13277-012-0632-8"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Bandi N, Vassella E. miR-34a and miR-15a\/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner. Mol Cancer. 2011;10:55. doi: 10.1186\/1476-4598-10-55","DOI":"10.1186\/1476-4598-10-55"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Si W, Li Y, Shao H, et al. MiR-34a inhibits breast cancer proliferation and progression by targeting Wnt1 in Wnt\/\u03b2-Catenin signaling pathway. Am J Med Sci. 2016;352 (2):191-9. doi: 10.1016\/j.amjms.2016.05.002","DOI":"10.1016\/j.amjms.2016.05.002"},{"key":"47","doi-asserted-by":"publisher","unstructured":"47. Liao H, Xiao Y, Hu Y, et al. Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK\/mTOR pathway in prostate cancer. Oncol Rep. 2016;35 (1):64-72. doi: 10.3892\/or.2015.4331","DOI":"10.3892\/or.2015.4331"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Zuo Y, Zheng W, Liu J, Tang Q, Wang SS, Yang XS. MiR-34a-5p\/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells. Neoplasma. 2020;67 (1):93-101. doi: 10.4149\/neo_2019_190202N106","DOI":"10.4149\/neo_2019_190202N106"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/92\/1\/92_JNMS.2025_92-116\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T04:56:10Z","timestamp":1741409770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/92\/1\/92_JNMS.2025_92-116\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2025_92-116","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"type":"print","value":"1345-4676"},{"type":"electronic","value":"1347-3409"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"article-number":"JNMS.2025_92-116"}}